Replies to post #188483 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Titrate the dose for the specific patient's size, weight and metabolism

Slide 15

The ideal pharmacogenomics test will be able to determine:
• Potential for a medication to be
effective – for this person
• The best dose of a medication –
for this person
• Avoid risk of serious side effects
– for this person

https://www.anavex.com/wp-content/uploads/2019/04/Anavex-Presentation-April-2019.pdf

Good luck and GOD bless,

[bennyboy1]

I agree with you 100%! Very well-done presentation. Cheers to ANAVEX going forward in a very professional manner for all to see!!!!!

[roygbiv]

Value-Creating Catalysts – Clinical updates from Phase 2 Parkinson’s disease dementia study, Phase
2b/3 Alzheimer’s disease and Phase 2 Rett syndrome studies anticipated in 2019. Clinical data publications
and additional indicationS to be announced in 2019.


I like it

AVXL TIME!

Thanks to all the reporters!